Who we are
What matters to us
Management
Supervisory Board
Scientific Advisory Board
Collaborations
What we do
Core areas
Bioinformatics
Analytical capabilities
Formulation development approach
Work with us
News & Events
Contact
Contact us
Legal Notice
Privacy Policy
General Terms and Conditions
Press Releases
Sep. 2008
LEUKOCARE announces 2.1 Mio EUR capital increase
Oct. 2005
Start of clinical trial for Leukocyte Inhibition Module (LIM)
1
2
3
4
5
6